chr2-112378125-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000302558.8(RGPD8):c.5191C>T(p.Leu1731Phe) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0012 ( 0 hom., cov: 4)
Exomes 𝑓: 0.00013 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
RGPD8
ENST00000302558.8 missense
ENST00000302558.8 missense
Scores
4
4
11
Clinical Significance
Conservation
PhyloP100: 7.30
Genes affected
RGPD8 (HGNC:9849): (RANBP2 like and GRIP domain containing 8) Predicted to contribute to GTPase activator activity. Predicted to be involved in NLS-bearing protein import into nucleus. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.013211906).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGPD8 | NM_001164463.1 | c.5191C>T | p.Leu1731Phe | missense_variant | 22/23 | ENST00000302558.8 | NP_001157935.1 | |
RGPD8 | XM_024453101.2 | c.5113C>T | p.Leu1705Phe | missense_variant | 22/23 | XP_024308869.1 | ||
RGPD8 | XM_047445676.1 | c.4336C>T | p.Leu1446Phe | missense_variant | 17/18 | XP_047301632.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGPD8 | ENST00000302558.8 | c.5191C>T | p.Leu1731Phe | missense_variant | 22/23 | 1 | NM_001164463.1 | ENSP00000306637.3 | ||
RGPD8 | ENST00000409750.5 | c.4771C>T | p.Leu1591Phe | missense_variant | 21/22 | 1 | ENSP00000386511.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 10AN: 8086Hom.: 0 Cov.: 4 FAILED QC
GnomAD3 genomes
AF:
AC:
10
AN:
8086
Hom.:
Cov.:
4
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000611 AC: 1AN: 1638Hom.: 0 AF XY: 0.00110 AC XY: 1AN XY: 906
GnomAD3 exomes
AF:
AC:
1
AN:
1638
Hom.:
AF XY:
AC XY:
1
AN XY:
906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000129 AC: 29AN: 224376Hom.: 0 Cov.: 0 AF XY: 0.000134 AC XY: 16AN XY: 119148
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
29
AN:
224376
Hom.:
Cov.:
0
AF XY:
AC XY:
16
AN XY:
119148
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00124 AC: 10AN: 8090Hom.: 0 Cov.: 4 AF XY: 0.00106 AC XY: 4AN XY: 3780
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
10
AN:
8090
Hom.:
Cov.:
4
AF XY:
AC XY:
4
AN XY:
3780
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2023 | The c.5191C>T (p.L1731F) alteration is located in exon 22 (coding exon 22) of the RGPD8 gene. This alteration results from a C to T substitution at nucleotide position 5191, causing the leucine (L) at amino acid position 1731 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;.
Vest4
MutPred
Loss of stability (P = 0.0557);.;
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at